The Impact of RWE on U.S. Pharmaceutical Market Access Strategies

The integration of Real-World Evidence (RWE) into healthcare decision-making is transforming the landscape of pharmaceutical development, pricing, and reimbursement strategies in the United States. To explore these advancements, the EVIDENCE 360: RWE, Pricing & Reimbursement Summit USA is scheduled for June 26-27, 2025, in Philadelphia.
Summit Overview
This two-day event aims to unite healthcare professionals, pharmaceutical leaders, policymakers, researchers, and data scientists to discuss the pivotal role of Real World Evidence in shaping healthcare poli

Optimizing Reimbursement Models with Real-World Evidence

The integration of Real-World Evidence (RWE) into healthcare decision-making is transforming how pharmaceutical companies approach Health Economics and Outcomes Research (HEOR), pricing, and reimbursement strategies. To delve into these advancements, the EVIDENCE 360: Real World Evidence, Pricing & Reimbursement Summit Europe is scheduled for 26th-27th May 2025 in Frankfurt, Germany.
Summit Overview
This two-day event is tailored for healthcare professionals, pharmaceutical leaders, policymakers, and researchers. It aims to explore the latest trends, challenges, an

HPAPI Development and Manufacturing

Developing HPAPIs involves navigating complex processes that prioritize both efficacy and safety. Manufacturers must implement robust contai